J Vettorazzi1, F V Torres2, T T de Ávila3, S H Martins-Costa4, D O Souza3, L V Portela3, J G Ramos4. 1. Department of Obstetrics and Gynecology, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS 90035, Brazil. Electronic address: janetev@terra.com.br. 2. Department of Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre, RS 90035, Brazil. Electronic address: fvtorres@gmail.com. 3. Department of Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre, RS 90035, Brazil. 4. Department of Obstetrics and Gynecology, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS 90035, Brazil.
Abstract
BACKGROUND: Serum S100B is a protein produced and released primarily by astrocytes of the Central Nervous System (CNS). Elevated levels of serum S100B are associated with several types of pathological conditions of the brain, including the eclampsia in pregnant women. The aim of this study was to compare serum S100B concentrations in pregnant women with severe and mild preeclampsia (PE) with S100B serum levels in normotensive pregnant women. MATERIAL AND METHODS: Serum S100B protein was measured in normotensive pregnant women (n=15) and in women with mild PE (n=12) or severe PE (n=34). The serum S100B level (μg/L) was determined by an luminometric assay. RESULTS: Sixty-one expectant mothers were studied, aged 26.6±8.7 (mean±SD) years and with a gestational age of 33.3±4.2 weeks. The severe PE group demonstrated higher S100B levels (0.20±0.19), as compared with mild PE (0.07±0.05) or normotensive groups (0.04±0.05). CONCLUSION: Elevated serum S100B levels in pregnant women with severe PE suggest that some kind of neural damage and subsequent astrocytic release of S100B is not dependent on the progression from severe preeclampsia to eclampsia.
BACKGROUND: Serum S100B is a protein produced and released primarily by astrocytes of the Central Nervous System (CNS). Elevated levels of serum S100B are associated with several types of pathological conditions of the brain, including the eclampsia in pregnant women. The aim of this study was to compare serum S100B concentrations in pregnant women with severe and mild preeclampsia (PE) with S100B serum levels in normotensive pregnant women. MATERIAL AND METHODS: Serum S100B protein was measured in normotensive pregnant women (n=15) and in women with mild PE (n=12) or severe PE (n=34). The serum S100B level (μg/L) was determined by an luminometric assay. RESULTS: Sixty-one expectant mothers were studied, aged 26.6±8.7 (mean±SD) years and with a gestational age of 33.3±4.2 weeks. The severe PE group demonstrated higher S100B levels (0.20±0.19), as compared with mild PE (0.07±0.05) or normotensive groups (0.04±0.05). CONCLUSION: Elevated serum S100B levels in pregnant women with severe PE suggest that some kind of neural damage and subsequent astrocytic release of S100B is not dependent on the progression from severe preeclampsia to eclampsia.
Authors: Lina Bergman; Pablo Torres-Vergara; Jeffrey Penny; Johan Wikström; Maria Nelander; Jose Leon; Mary Tolcher; James M Roberts; Anna-Karin Wikström; Carlos Escudero Journal: Curr Hypertens Rep Date: 2019-08-02 Impact factor: 5.369
Authors: Malin Andersson; Jonatan Oras; Sven Egron Thörn; Ove Karlsson; Peter Kälebo; Henrik Zetterberg; Kaj Blennow; Lina Bergman Journal: PLoS One Date: 2021-02-08 Impact factor: 3.240
Authors: Therese Friis; Anna-Karin Wikström; Jesenia Acurio; José León; Henrik Zetterberg; Kaj Blennow; Maria Nelander; Helena Åkerud; Helena Kaihola; Catherine Cluver; Felipe Troncoso; Pablo Torres-Vergara; Carlos Escudero; Lina Bergman Journal: Cells Date: 2022-02-24 Impact factor: 6.600